Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2013-11-20 Regulatory Filings
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
Business and R&D Update
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number header and the closing statement 'This information is provided by RNS'. It contains updates on business performance, R&D decisions (regarding Grass Mata MPL), and the appointment of a new R&D Director, all presented ahead of the Annual General Meeting (AGM). Since the text explicitly states the Chairman 'will update shareholders' at the AGM regarding these details, and the content is an update/presentation material rather than a formal statutory report (like 10-K or IR), it aligns best with the 'AGM Information' category, which covers presentations and materials shared during the AGM.
2013-11-20 English
Group of companies' accounts made up to 2013-06-30
Regulatory Filings
2013-10-29 English
Annual Report and Accounts
Report Publication Announcement Classification · 99% confidence The document is very short (1719 characters) and explicitly states that the 'Annual Report and Accounts' and 'Notice of Annual General Meeting' were posted to shareholders and are available on the company website. This fits the 'MENU VS MEAL' rule, indicating it is an announcement about the publication of reports rather than the reports themselves. The RNS Number (6915Q) and the content structure strongly suggest a regulatory announcement. Since it announces the publication of reports, the most appropriate classification is Report Publication Announcement (RPA). While it mentions the AGM Notice, RPA covers the announcement of report availability better than AGM-R (which is for the meeting materials themselves).
2013-10-16 English
Notification under AIM Rule Schedule Two (g)
Director's Dealing Classification · 99% confidence The document is identified by the RNS Number prefix ('RNS Number : 0827Q') and explicitly states it is an 'Allergy Therapeutics plc' announcement 'under AIM Rule Schedule Two (g) regarding Stephen Smith, a non-executive director'. This type of filing, disclosing personal share transactions or related dealings of a director, directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content points strongly to DIRS rather than the general RNS fallback category.
2013-10-09 English
Change of Adviser
Regulatory Filings Classification · 98% confidence The document is very short (992 characters) and contains an RNS Number ('0929P') and the date '27 September 2013'. The content announces a 'Change of Adviser' (appointment of Peel Hunt LLP as Nominated Adviser and Broker) and explicitly states, 'This information is provided by RNS The company news service from the London Stock Exchange'. This structure strongly indicates a general regulatory announcement that does not fit into the specific categories like ER, 10-K, or DIV. Therefore, it should be classified as a general Regulatory Filing (RNS).
2013-09-27 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 4625O' and contains a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES' form. This form details changes in significant share ownership (crossing the 23.31% threshold) by an entity (SOUTHERN FOX INVESTMENTS LTD.). This type of filing, which reports changes in major shareholdings, directly corresponds to the Major Shareholding Notification category.
2013-09-19 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.